BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21879395)

  • 21. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
    Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis.
    Robbins JR; Ryu S; Kalkanis S; Cogan C; Rock J; Movsas B; Kim JH; Rosenblum M
    Neurosurgery; 2012 Nov; 71(5):937-43. PubMed ID: 22806080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases.
    Ogiwara H; Kalakota K; Rakhra SS; Helenowski IB; Marymont MH; Kalapurakal JA; Mehta MP; Levy RB; Chandler JP
    J Neurooncol; 2012 May; 108(1):141-6. PubMed ID: 22426925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
    Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
    Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypofractionated stereotactic radiotherapy for brain metastases].
    Schlienger M; Nataf F; Huguet F; Pene F; Foulquier JN; Orthuon A; Roux FX; Touboul E
    Cancer Radiother; 2010 Apr; 14(2):119-27. PubMed ID: 20004125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
    Faruqi S; Ruschin M; Soliman H; Myrehaug S; Zeng KL; Husain Z; Atenafu E; Tseng CL; Das S; Perry J; Maralani P; Heyn C; Mainprize T; Sahgal A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):772-779. PubMed ID: 31928848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience.
    Dagnew E; Kanski J; McDermott MW; Sneed PK; McPherson C; Breneman JC; Warnick RE
    Neurosurg Focus; 2007 Mar; 22(3):E3. PubMed ID: 17608356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
    Minniti G; Paolini S; D'Andrea G; Lanzetta G; Cicone F; Confaloni V; Bozzao A; Esposito V; Osti M
    J Neurooncol; 2017 May; 132(3):455-462. PubMed ID: 28260130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
    Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
    J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
    Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis.
    Wijetunga A; Jayamanne D; Cook R; Parkinson J; Little N; Curtis J; Brown C; Back M
    J Clin Neurosci; 2020 Dec; 82(Pt A):155-161. PubMed ID: 33317725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status and recent advances in resection cavity irradiation of brain metastases.
    Minniti G; Niyazi M; Andratschke N; Guckenberger M; Palmer JD; Shih HA; Lo SS; Soltys S; Russo I; Brown PD; Belka C
    Radiat Oncol; 2021 Apr; 16(1):73. PubMed ID: 33858474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.